Bengaluru: The second wave of the coronavirus pandemic has had its terrible effects on India. Many are deprived of Oxygen, hospital beds and good treatment. 

To mitigate the problem, several people are doing their best. Social media has turned into a platform to help, with several users highlighting the amplifying the requests their receive. 

In the same way, the Indian Air Force, the Indian Railways have created special ventures to ensure that oxygen is supplied to all parts of the country. 

Vaccine makers are working overtime to produce as many doses as they can and help people get immunity. 

To produce such vaccinations is a phenomenal task. And to distribute it to all parts of the country is another. 

Tata Medical & Diagnostics is engaging with multiple vaccine makers like Johnson & Johnson (J&J) and AstraZeneca for marketing and distribution deals, reports Economic Times.

Furthermore, the company is already tapping in on the network of pharmacy e-commerce platform 1mg which the Tata Group is in the process of acquiring. The company is leveraging 1mg's network as it plans to enter the COVID-19 vaccination after 1 May when the scope will be opened up to the private sector enterprises, as reported by Swarajya. 

DRDO pitches in to build hospitals: 

The DRDO built hospitals having the capacity to house several beds in Lucknow. 
It has also used oxygen producing ability that is used in LCA called the OnBoard Oxygen Generating System (OBOGS). 

It is an indigenously built technology (specifically for India-manufactured aircract) used to supply oxygen to the aircrew by supplying oxygen using bleed air from the engine and separating oxygen from other components, using a process called Pressure Swing Adsorption Technology.  

It is in this way that the country is fighting the demon in whatever way possible and puts up a brave front as one single entity.